Form D · Venture Capital Fund

108 BioCapital Growth Fund, LP

Camana Bay, E9 · CIK 0002109243

Offering snapshot reported Feb 4, 2026 · SEC filing

Reported sold
$10.8M
Offering amount: $10.8M
Investors reported
10
Form D · investor count
Minimum accepted
$250K
Reported outside-investor minimum
First sale
Oct 27, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 4, 2026Initial$10,785,000No comparison10SEC filing

Offering details

Securities
Equity, Pooled investment fund
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-572348

Source: Form D, filed Feb 4, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
* 108 Bio Capital, Llc Executive
* 108 Bio Gp, Llc Executive
Sasha Bakhru Executive
Shom Jagtiani Executive
Steve Ward Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
72 Market Street, Suite 2206 Cassia Court, Po Box 30869
Camana Bay, E9, KY1-1204